KRAS and pancreatic neoplasm: Our in vivo testing of KRAS(G12D) inhibitors was conducted in two xenograft pancreatic tumor models: BALB/c nude mice subcutaneously inoculated with Panc 04.03 cells and C57BL/6 mice inoculated with KPC cells.